HTGF backs PS Biotech

The fresh funding will be used to accelerate the company's growth and to expand its product portfolio.

HTGF usually invests €500,000 at the seed stage, committing up to €2m to its portfolio companies in total. It is currently investing from its second fund, a €304m vehicle.

Previous funding
HTGF committed early-stage financing to PS Biotech in June and September 2013, according to unquote" data. The capital was used to bring the company's Feed Plate tool to market.

Company
PS Biotech span out of the RWTH Aachen and the DWI Leibniz Institute for Interactive Materials in May 2013. It develops, produces and markets polymer-based nutrient release systems in the industrial biotechnology segment. Its product screens thousands of clones to identify the optimal strain for industrial-scale production.

The Feed Plate tool has a range of release rates, substrates and plate formats, allowing for a wide range of micro-organisms to be cultivated. An early customer of the product was chemical manufacturing company Henkel. The company claims users can make significant savings using the product, as existing tools often provide inaccurate results.

People
Kristina Bruellhoff and Sebastian Selzer are managing directors and co-founders of PS Biotech. Christian Jung is investment manager at HTGF.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Expansion
• Healthcare
• Germany
• High-Tech Gründerfonds
• Unq2015Jan